Израиль - иврит - Ministry of Health

taro international ltd - clopidogrel 75 mg - film coated tablets - clopidogrel - clopidogrel is indicated in adults for the prevention of atherothrombotic events as follows:patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.patients suffering from acute coronary syndrome- non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave myocardial infarction (mi)), including patients undergoing a stent replacement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy

Израиль - иврит - Ministry of Health

eli lilly israel ltd - prasugrel as hydrochloride - טבליות מצופות פילם - prasugrel as hydrochloride 5 mg - platelet aggregation inhibitors, excl. heparin - effient, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in patients with acute coronary syndrome ( i.e. unstable angina, non-st segment elevation myocardial infarction [ua/nstemi] or st segment elevation myocardial infarction [stemi] undergoing primary or delayed percutaneous coronary intervention (pci).the increased efficacy should be balanced with the increased risk in patients with bleeding tendencyin those who had tia/cva in the past and in those above the age of 75 and a weight below 60 kg3.

Израиль - иврит - Ministry of Health

eli lilly israel ltd - prasugrel as hydrochloride - טבליות מצופות פילם - prasugrel as hydrochloride 10 mg - platelet aggregation inhibitors, excl. heparin - effient, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in patients with acute coronary syndrome ( i.e. unstable angina, non-st segment elevation myocardial infarction [ua/nstemi] or st segment elevation myocardial infarction [stemi] undergoing primary or delayed percutaneous coronary intervention (pci). the increased efficacy should be balanced with the increased risk in patients with bleeding tendencyin those who had tia/cva in the past and in those above the age of 75 and a weight below 60 kg3.

Израиль - иврит - Ministry of Health

abic marketing ltd, israel - prasugrel as hydrobromide - טבליות מצופות פילם - prasugrel as hydrobromide 10 mg - prasugrel

Израиль - иврит - Ministry of Health

abic marketing ltd, israel - prasugrel as hydrobromide - טבליות מצופות פילם - prasugrel as hydrobromide 5 mg - prasugrel

Израиль - иврит - Ministry of Health

abic marketing ltd, israel - ibuprofen - תרחיף - ibuprofen 20 mg/ml - ibuprofen

Израиль - иврит - Ministry of Health

מדיסון פארמה בע"מ - צוות טכני - for diagnostic of antagonism to aspirin, clopidogrel, prasugrel, iibiiia antagonist and platelet disorders

Израиль - иврит - Ministry of Health

abic marketing ltd, israel - ibuprofen - תרחיף - ibuprofen 100 mg / 5 ml - ibuprofen

Израиль - иврит - Ministry of Health

abic marketing ltd, israel - ibuprofen - תרחיף - ibuprofen 100 mg / 5 ml - ibuprofen

Израиль - иврит - Ministry of Health

astrazeneca (israel) ltd - ticagrelor - טבליות מצופות פילם - ticagrelor 90 mg - ticagrelor - ticagrelor - brilinta, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with acute coronary syndromes (unstable angina, non st elevation myocardial infarction [nstemi] or st elevation myocardial infarction [stemi]); including patients managed medically, and those who are managed with percutaneous coronary intervention (pci) or coronary artery by-pass grafting (cabg).